These findings suggest that ZGDHu-1 induces apoptosis by inhibiting the NF-κB signaling pathway in MCL cells partly, thereby providing evidence that ZGDHu-1 is a potential therapeutic molecule that may improve MCL patients’ outcomes. This evidence concerns the gene NFKB1 and mantle cell lymphoma.